Betatalassemia intermediária e menor (pediatria)
Cuidados de suporte
Quelação de ferro
Iron out for nontransfused thalassemia. (abre nova janela)
Fonte: Blood 2012;120(5):928-9.
Indexado: PubMed 22859709
DOI: 10.1182/blood-2012-06-433227
https://www.ncbi.nlm.nih.gov/pubmed/22859709 (abre nova janela)
Iron overload in β-thalassemia intermedia: an emerging concern. (abre nova janela)
Fonte: Curr Opin Hematol 2013;20(3):187-92.
Indexado: PubMed 23426199
DOI: 10.1097/MOH.0b013e32835f5a5c
https://www.ncbi.nlm.nih.gov/pubmed/23426199 (abre nova janela)
Deferasirox for the treatment of iron overload in non-transfusion-dependent thalassemia. (abre nova janela)
Fonte: Expert Rev Hematol 2013;6(5):495-509.
Indexado: PubMed 24083402
DOI: 10.1586/17474086.2013.827411
https://www.ncbi.nlm.nih.gov/pubmed/24083402 (abre nova janela)
Suplementos alimentares e outras terapias de apoio
Prevalance of iron deficiency in thalassemia minor: a study from tertiary hospital. (abre nova janela)
Fonte: Indian J Hematol Blood Transfus 2012;28(1):7-9.
Indexado: PubMed 23449336
DOI: 10.1007/s12288-011-0088-9
https://www.ncbi.nlm.nih.gov/pubmed/23449336 (abre nova janela)
Therapeutic roles of curcumin: lessons learned from clinical trials. (abre nova janela)
Fonte: AAPS J 2013;15(1):195-218.
Indexado: PubMed 23143785
DOI: 10.1208/s12248-012-9432-8
https://www.ncbi.nlm.nih.gov/pubmed/23143785 (abre nova janela)
Determining and surveying the role of carnitine and folic acid to decrease fatigue in β-thalassemia minor subjects. (abre nova janela)
Fonte: Pediatr Hematol Oncol 2013;30(8):742-7.
Indexado: PubMed 23458634
DOI: 10.3109/08880018.2013.771388
https://www.ncbi.nlm.nih.gov/pubmed/23458634 (abre nova janela)